Meta-analysis of relationship between CYP2E1 and ALDH2 polymorphisms and hepatocellular carcinoma risk  

出　　处：《中国药理学通报》2015年第B11期38-38,共1页Chinese Pharmacological Bulletin

摘　　要：The cytochrome P450 2El （ CYP2E1 ） and aldehyde dehydrogenase 2 （ALDH2） have been demonstrated that they were related to the development of hepatocellular carcinoma （HCC）. However, the associations have not been explained conclusively, and the combined analysis with the CYP2E1 Rsa I polymorphism and the ALDH2 pol- ymorphism have not been clarifed. In this study, we performed a meta-analysis to interpret the association between CYP2E1 and ALDH2 polymorphisms and HCC risk. Published literatures were retrieved from PubMed and Embase up to July, 2014. The pooled odds ratio （OR） with 95% confidence interval （CI） was calculated by using fixed- effects or random-effects model. A total of twelve case-controlled studies with 1 077 cancer cases and 2 000 controls concerning the CYP2E1 polymorphism were selected for this meta-analysis. The results indicated that there was no significantly associations between CYP2E1 polymorphism and risk of HCC （cl/c2 vs el/el ： OR - 1.11, 95% CI： 0.88-=1.39, P-0.38; c2/c2 vs el/el. OR -0.90, 95% CI. 0.54-=1.50, P-0.69; cl/c2 ＋ c2/c2 vs el/ el ： OR - 1.07, 95% CI： 0.89 -~ 1.30, P -0.47）. Further analysis of subgroup based on the ethnicity also showed no statistically significant associated with risk of HCC between the East Asians and the Europeans. In addi- tion, eight studies including 911 cases and 1 903 controls were included in this meta-analysis about the association between ALDH2 polymorphism and HCC risk. Results Based on our study also showed no significant association between ALDH2 polymorphism and the risk of HCC risk （ ＊ 1/＊ 2 vs ＊ 1/＊ 1： OR -0. 92, 95% CI： 0.65 -＊ 1.32, P-0.66; ,2/,2 vs ＊ 1/＊ 1. OR -0.82, 95% CI. 0.57-=1.18, P-0.28, ＊ 1/,2 ＋ ,2/,2 vs ＊ 1/＊ 1 ： OR -0.90, 95% CI. 0. 63 -- 1.29, P -0. 57）. The present meta-analysis indicated that there was no sig- nificant association between CYP2E1 polymorphism or ALDH2 polymorphism and HCC risk in the East Asians and the Europeans.

关 键 词：CYP2E1 ALDH2 Polymorphism HEPATOCELLULAR carcinoma cancer RISK META-ANALYSIS 

分 类 号：R[医药卫生]